Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Esther Navarro-Manzano"'
Autor:
Javier Cuenca-Guardiola, Belén de la Morena-Barrio, Esther Navarro-Manzano, Jonathan Stevens, Willem H. Ouwehand, Nicholas S. Gleadall, Javier Corral, Jesualdo Tomás Fernández-Breis
Publikováno v:
iScience, Vol 26, Iss 11, Pp 108214- (2023)
Summary: Repetitive sequences represent about 45% of the human genome. Some are transposable elements (TEs) with the ability to change their position in the genome, creating genetic variability both as insertions or deletions, with potential pathogen
Externí odkaz:
https://doaj.org/article/8554cdc9d6204569bedc196f74acd6b0
Autor:
Esmeralda García-Torralba, Esther Navarro Manzano, Gines Luengo-Gil, Pilar De la Morena Barrio, Asunción Chaves Benito, Miguel Pérez-Ramos, Beatriz Álvarez-Abril, Alejandra Ivars Rubio, Elisa García-Garre, Francisco Ayala de la Peña, Elena García-Martínez
Publikováno v:
Frontiers in Oncology. 13
BackgroundUp to 30% of breast cancer (BC) patients treated with neoadjuvant chemotherapy (NCT) will relapse. Our objective was to analyze the predictive capacity of several markers associated with immune response and cell proliferation combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b84e89035dfb742e8b42450e6cb7527
https://doi.org/10.3389/fonc.2023.1182725
https://doi.org/10.3389/fonc.2023.1182725
Autor:
Esmeralda García-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro-Manzano, Noel Blaya Boluda, Pilar de la Morena Barrio, Elisa García-Garre, Francisco Martínez Díaz, Asunción Chaves-Benito, Elena García-Martínez, Francisco Ayala de la Peña
Publikováno v:
Cancers; Volume 15; Issue 10; Pages: 2846
Luminal breast cancer (BC) is associated with less immune activation, and the significance of stromal lymphocytic infiltration (sTIL) is more uncertain than in other BC subtypes. The aim of this study was to investigate the predictive and prognostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb0a063779405d6bfd0e97829ceef4f
Autor:
Esmeralda Garcia-Torralba, Beatriz Álvarez-Abril, Carlos Bravo-Pérez, Esther Navarro Manzano, Pilar de la Morena Barrio, Alejandra Ivars Rubio, Elisa García-Garre, Gema Marín Zafra, Francisco Ayala de la Peña, Elena García-Martínez
Publikováno v:
Cancer Research. 82:P4-07
Introduction and objectives Up to 30% of early breast cancer (BC) patients treated with neoadjuvant chemotherapy will have systemic relapse during the follow-up. The integration of clinical, analytical and molecular parameters associated to tumor bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c9f399f781ed7c0377e3a0d37376a8
https://doi.org/10.1158/1538-7445.sabcs21-p4-07-03
https://doi.org/10.1158/1538-7445.sabcs21-p4-07-03
Autor:
Esmeralda Garcia-Torralba, Beatriz Álvarez-Abril, Carlos Bravo-Pérez, Esther Navarro Manzano, Pilar de la Morena Barrio, Alejandra Ivars Rubio, Elisa García-Garre, Gema Marín Zafra, Francisco Ayala de la Peña, Elena García-Martínez
Publikováno v:
Cancer Research. 82:P4-07
Introduction. There are still 30-40% of patients with early breast cancer (BC) that relapse after neoadjuvant chemotherapy (NAC). New prognostic biomarkers are needed. Current evidence shows that both markers of antitumor local and systemic immune re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507ac1e5a2807465931c1c956b00edc3
https://doi.org/10.1158/1538-7445.sabcs21-p4-07-11
https://doi.org/10.1158/1538-7445.sabcs21-p4-07-11
Autor:
Gines Luengo-Gil, Enrique Gonzalez-Billalabeitia, Sergio Alejo Perez-Henarejos, Esther Navarro Manzano, Asuncion Chaves-Benito, Elena Garcia-Martinez, Elisa Garcia-Garre, Vicente Vicente, Francisco Ayala de la Peña
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194638 (2018)
BACKGROUND:Angiogenesis is a key process for tumor progression and a target for treatment. However, the regulation of breast cancer angiogenesis and its relevance for clinical resistance to antiangiogenic drugs is still incompletely understood. Recen
Externí odkaz:
https://doaj.org/article/dd106c7a60b943b68c3fd6b0448f99f6
Autor:
Giulia Petroni, Kenneth Gouin, Claudia Galassi, Aitziber Buqué, Norma Bloy, Takahiro Yamazaki, Ai Sato, Carlos Jiménez-Cortegana, Alexander Kirchmair, Chiara Massa, Carlos Eduardo De Andrea, Belén Navarro, Irantzu Serrano, Esther Navarro Manzano, Francesca Finotello, Xi Zhou, Elena García-Martínez, María Rodríguez-Ruiz, Barbara Seliger, Víctor Sánchez-Margalet, Luis de la Cruz-Merino, Heather McArthur, Silvia Formenti, Simon Knott, Lorenzo Galluzzi
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3ac6ba1552174d071edcd2776fc64be
https://doi.org/10.1136/jitc-2022-sitc2022.1144
https://doi.org/10.1136/jitc-2022-sitc2022.1144
Autor:
Maria Esperanza Guirao Garcia, Esmeralda García-Torralba, Beatriz Alvarez Abril, Francisco Ayala de la Peña, Alejandra Ivars Rubio, Pilar de la Morena Barrio, Elena Garcia Martinez, Esther Navarro Manzano, Elisa García Garre, Gema Marin Zafra
Publikováno v:
Cancer Research. 81:PS6-54
Introduction and objectives Pathologic complete response (pCR, ypT0/Tis ypN0) after neoadjuvant chemotherapy (nCT) in early breast cancer (BC) is associated with higher survival rate. Controversy about the prognostic significance of low-volume or mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa053fe42970488795cb742528bb85bb
https://doi.org/10.1158/1538-7445.sabcs20-ps6-54
https://doi.org/10.1158/1538-7445.sabcs20-ps6-54
Autor:
Esther Navarro-Manzano, Ginés Luengo-Gil, Rocío González-Conejero, Elisa García-Garre, Elena García-Martínez, Esmeralda García-Torralba, Asunción Chaves-Benito, Vicente Vicente, Francisco Ayala de la Peña
Publikováno v:
Cancers; Volume 14; Issue 10; Pages: 2390
While the role of miR-200c in cancer progression has been established, its expression and prognostic role in breast cancer is not completely understood. The predictive role of miR-200c in response to chemotherapy has also been suggested by some studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75fd6e703e2402974caba8b9367ecbae
Autor:
Alejandra Ivars Rubio, Maria Piedad Fernandez Perez, Esmeralda García-Torralba, Elena García-Martínez, Esther Navarro Manzano, Asunción Chaves Benito, Raul Teruel Montoya, Francisco Martínez Díaz, Francisco Ayala de la Peña, Pilar de la Morena Barrio
Background: Endocrine resistance is a major cause of therapeutic failure in metastatic breast cancer (MBC). The information provided by DNA sequencing of plasma cell free DNA (cfDNA) and by the analysis of circulating tumor cells (CTC) may be useful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3b94cf28a2c76da79cd5f0067642e8c
https://doi.org/10.21203/rs.3.rs-57674/v1
https://doi.org/10.21203/rs.3.rs-57674/v1
